World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
41700
World Ranking
18235
National Ranking
9095

Jerzy Lasota publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jerzy Lasota sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 161 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jerzy Lasota D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jerzy Lasota sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jerzy Lasota is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with specific subfields that include Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine, and Surgery.

The scientist's main topics of study encompass several areas: sarcoma diagnosis and treatment, tumors and oncological cases, genetic factors in colorectal cancer, peptidase inhibition and analysis, gastrointestinal tumor research and treatment, vascular tumors and angiosarcomas, and PARP inhibition in cancer therapy.

Lasota has an active publication record with notable papers such as:

  • Colorectal Adenocarcinomas Harboring ALK Fusion Genes, 2020, The American Journal of Surgical Pathology
  • PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors, 2022, The American Journal of Surgical Pathology
  • Gastrointestinal stromal tumours, 2021, Nature Reviews Disease Primers
  • Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology, 2023, The American Journal of Surgical Pathology
  • Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature, 2022, Modern Pathology

The venues where Lasota has frequently published include:

  • The American Journal of Surgical Pathology
  • The Journal of Pathology Clinical Research
  • Applied Immunohistochemistry & Molecular Morphology
  • Nature Reviews Disease Primers
  • Modern Pathology

Among frequent co-authors collaborating extensively with Lasota are:

  • Markku Miettinen
  • Maciej Kaczorowski
  • Małgorzata Chłopek
  • Janusz Ryś
  • Artur Kowalik

Best Publications

  • Diagnosis of gastrointestinal stromal tumors: A consensus approach.

    Christopher D.M. Fletcher;Jules J. Berman;Christopher Corless;Fred Gorstein

  • Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

    Markku Miettinen;Jerzy Lasota

  • Gastrointestinal stromal tumors: Pathology and prognosis at different sites

    Markku Miettinen;Jerzy Lasota

  • Gastrointestinal Stromal Tumors: Review on Morphology, Molecular Pathology, Prognosis, and Differential Diagnosis

    Markku Miettinen;Jerzy Lasota

  • Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

    Markku Miettinen;Leslie H Sobin;Jerzy Lasota

  • Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases

    Markku Miettinen;Janusz Kopczynski;Hala R. Makhlouf;Maarit Sarlomo-Rikala

  • Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.

    Markku Miettinen;Wa'el El-Rifai;Wa'el El-Rifai;Leslie H L Sobin;Leslie H L Sobin;Jerzy Lasota;Jerzy Lasota

  • Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

    Markku Miettinen;Hala Makhlouf;Leslie H Sobin;Jerzy Lasota

  • Mutations in Exon 11 of c-Kit Occur Preferentially in Malignant versus Benign Gastrointestinal Stromal Tumors and Do Not Occur in Leiomyomas or Leiomyosarcomas

    Jerzy Lasota;Marek Jasinski;Maarit Sarlomo-Rikala;Markku Miettinen

  • Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review

    Markku Miettinen;Mourad Majidi;Jerzy Lasota

  • KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation.

    Markku Miettinen;Jerzy Lasota

  • Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas.

    Markku Miettinen;Maarit Sarlomo-Rikala;Leslie H. Sobin;Jerzy Lasota

  • Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases.

    Markku Miettinen;John F Fetsch;Leslie H Sobin;Jerzy Lasota

  • DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.

    Markku Miettinen;Zeng-Feng Wang;Jerzy Lasota

  • Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours

    J Lasota;M Miettinen

  • Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases.

    Markku Miettinen;Maarit Sarlomo-Rikala;Leslie H. Sobin;Jerzy Lasota

  • Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases.

    Jerzy Lasota;Agnieszka Wozniak;Agnieszka Wozniak;Maarit Sarlomo-Rikala;Janusz Rys

  • Gastrointestinal Stromal Tumors (GISTs): Definition, Occurrence, Pathology, Differential Diagnosis and Molecular Genetics*

    Markku Miettinen;Jerzy Lasota

  • SUCCINATE DEHYDROGENASE DEFICIENT GISTS – A CLINICOPATHOLOGIC, IMMUNOHISTOCHEMICAL, AND MOLECULAR GENETIC STUDY OF 66 GASTRIC GISTS WITH PREDILECTION TO YOUNG AGE

    Markku Miettinen;Zeng-Feng Wang;Maarit Sarlomo-Rikala;Czeslaw Osuch

  • Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature.

    Markku Miettinen;Jerzy Lasota;Leslie H Sobin

Frequent Co-Authors

Markku Miettinen
Markku Miettinen National Cancer Institute
Leslie H. Sobin
Leslie H. Sobin National Cancer Institute
Klaus Weber
Klaus Weber Max Planck Society
Mary Osborn
Mary Osborn Max Planck Institute for Biophysical Chemistry
Christopher L. Corless
Christopher L. Corless Oregon Health & Science University
Lee J. Helman
Lee J. Helman Children's Hospital of Los Angeles
Leif C. Andersson
Leif C. Andersson University of Helsinki
Sakari Knuutila
Sakari Knuutila University of Helsinki
Paul S. Meltzer
Paul S. Meltzer National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are many alternative paths in healthcare that don’t require pre-medical degrees or traditional medical school routes. For those with a bachelor’s in a non-nursing field who want to transition quickly into advanced nursing roles, direct entry msn programs for non-nursing majors online offer intensive coursework and flexible online options.

If you prefer a faster track into nursing, several online adn programs for non nurses provide pathways to become a registered nurse without extensive prerequisites.

Healthcare careers are also accessible through administrative roles. For example, there are a variety of medical billing and coding schools that accept fafsa, which can ease financial burdens and open doors to well-paying positions in medical administration.

Some nursing programs now remove barriers for applicants by not requiring standardized entrance tests. Explore options like an lpn program no entrance exam for a streamlined admissions process.

These online degrees and alternative career pathways provide multiple entry points into the growing healthcare sector, catering to diverse backgrounds and career goals.

Best Scientists Citing Jerzy Lasota

Trending Scientists